Brain cholecystokinin-8 immunoreactivity in rats with experimental liver cirrhosis

F. Salerno; C. Bonato; A. E. Panerai; A. Martini; A. Malesci

doi:10.1016/S0024-3205(83)80012-5

Brain cholecystokinin-8 immunoreactivity in rats with experimental liver cirrhosis

F. Salerno, C. Bonato, A. E. Panerai, A. Martini, A. Malesci

Research output: Contribution to journal › Article › peer-review

Abstract

Cholecystokinin-8 like immunoreactivity (CCK-8 IR) was measured in different brain regions of rats with experimental liver cirrhosis. A statistically significant reduction of CCK-8 content was observed in the hypothalamus of cirrhotic rats. No significant modification of brain CCK fractionation pattern was observed in treated animals as compared to controls. The decrease of CCK-8 IR parallels the recently reported hypothalamic depletion of βendorphin in cirrhotic rats confirming the central neuropeptides are affected by chronic liver failure.

Original language	English
Pages (from-to)	377-381
Number of pages	5
Journal	Life Sciences
Volume	33
Issue number	4
DOIs	https://doi.org/10.1016/S0024-3205(83)80012-5
Publication status	Published - 1983

ASJC Scopus subject areas

Pharmacology

Access to Document

10.1016/S0024-3205(83)80012-5

Fingerprint Dive into the research topics of 'Brain cholecystokinin-8 immunoreactivity in rats with experimental liver cirrhosis'. Together they form a unique fingerprint.

Cite this

@article{603597a5a00443ac941dc76df41bad65,

title = "Brain cholecystokinin-8 immunoreactivity in rats with experimental liver cirrhosis",

abstract = "Cholecystokinin-8 like immunoreactivity (CCK-8 IR) was measured in different brain regions of rats with experimental liver cirrhosis. A statistically significant reduction of CCK-8 content was observed in the hypothalamus of cirrhotic rats. No significant modification of brain CCK fractionation pattern was observed in treated animals as compared to controls. The decrease of CCK-8 IR parallels the recently reported hypothalamic depletion of βendorphin in cirrhotic rats confirming the central neuropeptides are affected by chronic liver failure.",

author = "F. Salerno and C. Bonato and Panerai, {A. E.} and A. Martini and A. Malesci",

year = "1983",

doi = "10.1016/S0024-3205(83)80012-5",

language = "English",

volume = "33",

pages = "377--381",

journal = "Life Sciences",

issn = "0024-3205",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Brain cholecystokinin-8 immunoreactivity in rats with experimental liver cirrhosis

AU - Salerno, F.

AU - Bonato, C.

AU - Panerai, A. E.

AU - Martini, A.

AU - Malesci, A.

PY - 1983

Y1 - 1983

N2 - Cholecystokinin-8 like immunoreactivity (CCK-8 IR) was measured in different brain regions of rats with experimental liver cirrhosis. A statistically significant reduction of CCK-8 content was observed in the hypothalamus of cirrhotic rats. No significant modification of brain CCK fractionation pattern was observed in treated animals as compared to controls. The decrease of CCK-8 IR parallels the recently reported hypothalamic depletion of βendorphin in cirrhotic rats confirming the central neuropeptides are affected by chronic liver failure.

AB - Cholecystokinin-8 like immunoreactivity (CCK-8 IR) was measured in different brain regions of rats with experimental liver cirrhosis. A statistically significant reduction of CCK-8 content was observed in the hypothalamus of cirrhotic rats. No significant modification of brain CCK fractionation pattern was observed in treated animals as compared to controls. The decrease of CCK-8 IR parallels the recently reported hypothalamic depletion of βendorphin in cirrhotic rats confirming the central neuropeptides are affected by chronic liver failure.

UR - http://www.scopus.com/inward/record.url?scp=84878779762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878779762&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(83)80012-5

DO - 10.1016/S0024-3205(83)80012-5

M3 - Article

C2 - 6308371

AN - SCOPUS:84878779762

VL - 33

SP - 377

EP - 381

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 4

ER -